MedTrace Logo

Frailty Syndrome of Post-cancer Treatment Eldery Patients

NCT04746768 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-06-08

No results posted yet for this study

Summary

Decrease the prevalence of frailty syndrome in individuals with complete response of cancer.

Conditions

  • Frailty Syndrome
  • Exercise
  • Nutritional Support
  • Cancer

Interventions

COMBINATION_PRODUCT

exercise and nutritional support

exercise and nutritional support program during an active support phase (0 to 6 months) followed by an empowerment phase (from 6 to 12 months)

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Gaëtan Gavazzi, MD, PhD · University Hospital, Grenoble

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2023-01-31
Completion
2024-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04746768 on ClinicalTrials.gov